ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

Raise Cigarette Taxes, Fully Fund Bypass Budget, Increase Biomedical research Support, NCAB Urges

October 6, 1989

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

ONS Scientific Program Grows

June 20, 1980